Business
Coronavirus vaccine: Oxford, AstraZeneca resume trial after patient’s serious side-effect – PerthNow
Days after a vaccine trial was suspended following a reported side-effect in a UK patient, Oxford University has announced the study will resume.
Oxford University has announced it is resuming a trial for a coronavirus vaccine it is developing with pharmaceutical company AstraZeneca, a move that comes days after the study was suspended following a reported side-effect in a UK patient.
In a statement on Saturday, the university confirmed the restart across all of its UK clinical trial sites after regulators gave the go-ahead following the pause on Sunday.
The independent review process has concluded and following the recommendations of…
-
Business24 hours agoWhere will Berkshire Hathaway be in 1 year?
-
Noosa News18 hours agoTwo trapped and fighting for life after major three-vehicle crash in Brisbane
-
Business19 hours agoUp 105% in a year, are Pro Medicus shares still a good buy today?
-
Business17 hours agoEverything you need to know about the Coles dividend